Published : Jul-2018
No. of Pages : 42
1 Table of Contents 2
1.1 List of Tables 4
1.2 List of Figures 4
2 Introduction 5
2.1 Wireless and Ambulatory Monitoring Overview 5
3 Products under Development 6
3.1 Wireless and Ambulatory Monitoring - Pipeline Products by Stage of Development 6
3.2 Wireless and Ambulatory Monitoring - Pipeline Products by Segment 7
3.3 Wireless and Ambulatory Monitoring - Pipeline Products by Territory 8
3.4 Wireless and Ambulatory Monitoring - Pipeline Products by Regulatory Path 9
3.5 Wireless and Ambulatory Monitoring - Pipeline Products by Estimated Approval Date 10
4 Wireless and Ambulatory Monitoring - Pipeline Products under Development by Companies 11
4.1 Wireless and Ambulatory Monitoring Companies - Pipeline Products by Stage of Development 11
4.2 Wireless and Ambulatory Monitoring - Pipeline Products by Stage of Development 12
5 Wireless and Ambulatory Monitoring Companies and Product Overview 13
5.1 Aclaris Medical, LLC Company Overview 13
5.1.1 Aclaris Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 13
5.2 DoseCue, LLC Company Overview 14
5.2.1 DoseCue, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
5.3 Ecole Polytechnique Federale de Lausanne Company Overview 15
5.3.1 Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 15
5.4 LifeSignals Company Overview 16
5.4.1 LifeSignals Pipeline Products & Ongoing Clinical Trials Overview 16
5.5 Mayo Clinic Company Overview 17
5.5.1 Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 17
5.6 Physical Activity Innovations, Inc. Company Overview 18
5.6.1 Physical Activity Innovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
5.7 Stanford University Company Overview 19
5.7.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 19
5.8 University of California Los Angeles Company Overview 20
5.8.1 University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 20
5.9 University of California San Diego Company Overview 21
5.9.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 21
5.10 University of Michigan Company Overview 22
5.10.1 University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 22
5.11 University of Michigan Pediatric Device Consortium Company Overview 23
5.11.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 23
6 Wireless and Ambulatory Monitoring- Recent Developments 24
6.1 May 24, 2018: Quality Systems Reports Fiscal 2018 Fourth Quarter and Year-End Results 24
6.2 May 15, 2018: Vaso Announces Financial Results for First Quarter 2018 24
6.3 May 07, 2018: Vaso Names Jane Moen as President of VasoHealthcare 25
6.4 May 02, 2018: Masimo Reports First Quarter 2018 Financial Results 26
6.5 Apr 24, 2018: Established Clinician Betty Rabinowitz, MD, FACP, Appointed as NextGen Healthcare's Chief Medical Officer 27
6.6 Apr 23, 2018: SRL Diagnostics looks to increase retail presence in Kolkata 27
6.7 Mar 01, 2018: NextGen Healthcare Launches New Corporate Logo And Brand Identity 28
6.8 Feb 27, 2018: Masimo Reports Fourth Quarter 2017 Financial Results 28
6.9 Feb 05, 2018: Embrace by Empatica is the world's first smart watch to be cleared by FDA for use in Neurology 29
6.10 Jan 25, 2018: Quality Systems Reports Fiscal 2018 Third Quarter Results 30
6.11 Jan 19, 2018: School of Engineering awarded two ERC Consolidator Grants 30
6.12 Dec 19, 2017: New manufacturing business in Innokas Kempele factory: the series production of Monidrop Infusion Therapy device has been started 31
6.13 Dec 01, 2017: NextGen Healthcare Announces Jeffrey D. Linton as Executive Vice President, General Counsel, and Secretary 33
6.14 Nov 27, 2017: Masimo Announces FDA Clearance and Worldwide Release of NomoLine Capnography Sampling Lines 33
6.15 Nov 01, 2017: SunTech Medical Achieves ISO 13485 with MDSAP Certification 34
6.16 Oct 31, 2017: Masimo Reports Third Quarter 2017 Financial Results 34
6.17 Oct 26, 2017: Quality Systems Reports Fiscal 2018 Second Quarter Results 35
6.18 Aug 23, 2017: Julie Klapstein Elected to Quality Systems Board of Directors 36
6.19 Aug 02, 2017: SAMHSA announces $6 million in grants to support the International President's Emergency Plan for AIDS Relief Addiction Technology Transfer Centers 36
6.20 Aug 02, 2017: Masimo Reports Second Quarter 2017 Financial Results 37
6.21 Aug 01, 2017: Quality Systems Reports Fiscal 2018 First Quarter Results 37
7 Appendix 39
7.1 Methodology 39
7.2 About GlobalData 42
7.3 Contact Us 42
7.4 Disclaimer 42
1.1 List of Tables
Table 1: Wireless and Ambulatory Monitoring - Pipeline Products by Stage of Development 6
Table 2: Wireless and Ambulatory Monitoring - Pipeline Products by Segment 7
Table 3: Wireless and Ambulatory Monitoring - Pipeline Products by Territory 8
Table 4: Wireless and Ambulatory Monitoring - Pipeline Products by Regulatory Path 9
Table 5: Wireless and Ambulatory Monitoring - Pipeline Products by Estimated Approval Date 10
Table 6: Wireless and Ambulatory Monitoring Companies - Pipeline Products by Stage of Development 11
Table 7: Wireless and Ambulatory Monitoring - Pipeline Products by Stage of Development 12
Table 8: Aclaris Medical, LLC Pipeline Products & Ongoing Clinical Trials Overview 13
Table 9: Ambulatory PTSD Monitor - Product Status 13
Table 10: Ambulatory PTSD Monitor - Product Description 13
Table 11: DoseCue, LLC Pipeline Products & Ongoing Clinical Trials Overview 14
Table 12: DoseCue Mobile System - Product Status 14
Table 13: DoseCue Mobile System - Product Description 14
Table 14: Ecole Polytechnique Federale de Lausanne Pipeline Products & Ongoing Clinical Trials Overview 15
Table 15: Wireless Under-Skin Implant - Product Status 15
Table 16: Wireless Under-Skin Implant - Product Description 15
Table 17: LifeSignals Pipeline Products & Ongoing Clinical Trials Overview 16
Table 18: WiPoint Mobile Receiver - HR1120 - Product Status 16
Table 19: WiPoint Mobile Receiver - HR1120 - Product Description 16
Table 20: Mayo Clinic Pipeline Products & Ongoing Clinical Trials Overview 17
Table 21: Wireless Medical Monitoring Platform (MS, PD) - Product Status 17
Table 22: Wireless Medical Monitoring Platform (MS, PD) - Product Description 17
Table 23: Physical Activity Innovations, Inc. Pipeline Products & Ongoing Clinical Trials Overview 18
Table 24: Fit Companion - Product Status 18
Table 25: Fit Companion - Product Description 18
Table 26: Stanford University Pipeline Products & Ongoing Clinical Trials Overview 19
Table 27: Extravascular Lung Water Monitor - Product Status 19
Table 28: Extravascular Lung Water Monitor - Product Description 19
Table 29: University of California Los Angeles Pipeline Products & Ongoing Clinical Trials Overview 20
Table 30: Multi-Modal Depth-Resolved Tissue Status Monitor - Product Status 20
Table 31: Multi-Modal Depth-Resolved Tissue Status Monitor - Product Description 20
Table 32: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 21
Table 33: Portable Ambulatory Doppler Blood Flow Measurement System - Product Status 21
Table 34: Portable Ambulatory Doppler Blood Flow Measurement System - Product Description 21
Table 35: University of Michigan Pipeline Products & Ongoing Clinical Trials Overview 22
Table 36: Electro-Magnetic Cuff Flow Sensor - Product Status 22
Table 37: Electro-Magnetic Cuff Flow Sensor - Product Description 22
Table 38: University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 23
Table 39: Wireless Accelerometer - Product Status 23
Table 40: Wireless Accelerometer - Product Description 23
Table 41: Glossary 41
1.2 List of Figures
Figure 1: Wireless and Ambulatory Monitoring - Pipeline Products by Stage of Development 6
Figure 2: Wireless and Ambulatory Monitoring - Pipeline Products by Segment 7
Figure 3: Wireless and Ambulatory Monitoring - Pipeline Products by Territory 8
Figure 4: Wireless and Ambulatory Monitoring - Pipeline Products by Regulatory Path 9
Figure 5: Wireless and Ambulatory Monitoring - Pipeline Products by Estimated Approval Date 10
